Alpha-synuclein

Mar 19, 2018

The Michael J. Fox Foundation for Parkinson's Research Announces Availability of $7 Million in Fall 2018 Research Funding to Expand Understanding of Parkinson's Disease and Accelerate Drug Development

Feb 22, 2018

Shedding a Tear May Help Diagnose Parkinson's Disease

Jan 16, 2018

APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease

Dec 19, 2017

Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease

Nov 22, 2017

Global Alpha Synuclein Market Competition by Top Manufacturers - ReportsnReports

Nov 08, 2017

Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson's Disease Research

Oct 24, 2017

Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases

Oct 13, 2017

BioArctic's Patent for its Product Candidate Antibody BAN0805, for Parkinson's Disease, is Now Granted in Europe

Aug 29, 2017

New Antibodies Target Structures Shared by Proteins Thought to Worsen Several Neurological Diseases

Jun 07, 2017

AFFiRiS Announces Top Line Results of First-in-Human Clinical Study Using AFFITOPE® PD03A, Confirming Immunogenicity and Safety Profile in Parkinson's Disease Patients